Alchemia Ltd – Strategy, SWOT and Corporate Finance Report

Alchemia Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Alchemia Ltd (Alchemia) is an early stage biopharmaceutical company that focuses on the discovery and development of drugs for the treatment of various diseases. It sold the worldwide exclusive intellectual property rights to its product, Fondaparinux sodium (a generic version of the anticoagulant drug Arixtra, approved in the US and Europe for the treatment of deep vein thrombosis and pulmonary embolism), to Dr. Reddy’s Laboratories. The company holds patents associated with VAST, its proprietary drug discovery platform. Alchemia is headquartered in South Melbourne, Victoria, Australia.

Scope

Detailed information on Alchemia Ltd required for business and competitor intelligence needs

A study of the major internal and external factors affecting Alchemia Ltd in the form of a SWOT analysis

An in-depth view of the business model of Alchemia Ltd including a breakdown and examination of key business segments

News about Alchemia Ltd, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Alchemia Ltd and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Alchemia Ltd as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Alchemia Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Sirtex Medical Ltd

Mesoblast Ltd

Bionomics Ltd

Benitec Biopharma Ltd

Antisense Therapeutics Ltd

Acrux Ltd

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1 - About the Company 5

Alchemia Ltd - Key Facts 5

Alchemia Ltd - Key Employees 6

Alchemia Ltd - Key Employee Biographies 7

Alchemia Ltd - Major Products and Services 8

Alchemia Ltd - History 9

Alchemia Ltd - Locations And Subsidiaries 11

Head Office 11

Other Locations & Subsidiaries 11

Section 2 Company Analysis 12

Company Overview 12

Alchemia Ltd - Business Description 13

R&D Overview 13

Alchemia Ltd - SWOT Analysis 14

SWOT Analysis - Overview 14

Alchemia Ltd - Strengths 14

Alchemia Ltd - Weaknesses 15

Alchemia Ltd - Opportunities 16

Alchemia Ltd - Threats 17

Alchemia Ltd - Key Competitors 18

Section 3 Company Financial Ratios 19

Financial Ratios - Capital Market Ratios 19

Financial Ratios - Annual Ratios 20

Performance Chart 22

Financial Performance 22

Financial Ratios - Interim Ratios 23

Financial Ratios - Ratio Charts 24

Section 4 Company’s Lifesciences Financial Deals and Alliances 25

Alchemia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25

Alchemia Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 26

Alchemia Ltd, Recent Deals Summary 27

Section 5 Appendix 28

Methodology 28

Ratio Definitions 28

About GlobalData 32

Contact Us 32

Disclaimer 32

List of Tables

List of Tables

Alchemia Ltd, Key Facts 5

Alchemia Ltd, Key Employees 6

Alchemia Ltd, Key Employee Biographies 7

Alchemia Ltd, Major Products and Services 8

Alchemia Ltd, History 9

Alchemia Ltd, Subsidiaries 11

Alchemia Ltd, Key Competitors 18

Alchemia Ltd, Ratios based on current share price 19

Alchemia Ltd, Annual Ratios 20

Alchemia Ltd, Annual Ratios (Cont…1) 21

Alchemia Ltd, Interim Ratios 23

Alchemia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25

Alchemia Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 26

Alchemia Ltd, Recent Deals Summary 27

Currency Codes 28

Capital Market Ratios 28

Equity Ratios 29

Profitability Ratios 29

Cost Ratios 30

Liquidity Ratios 30

Leverage Ratios 31

Efficiency Ratios 31

List of Figures

List of Figures

Alchemia Ltd, Performance Chart (2014 – 2018) 22

Alchemia Ltd, Ratio Charts 24

Alchemia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25

Alchemia Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 26

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports